Synthetic thymosin beta-4 fragment studied in cell-migration models.
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Cell migration and repair pathways associated with thymosin beta-4 fragments. The fragment and the full-length protein are not interchangeable; findings on full-length thymosin beta-4 do not establish benefits for a TB-500 formulation.
Compound identity, formulation and limited direct evidence require careful distinction from related molecules. No therapeutic benefit is established for this catalogue product.
PMID: 20179146
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.